Budget 2019: Seek incentives for pharma sector

By Ravi Mathur

The pharma sector could be incentivized in the budget for adopting global practices & standards which enable counterfeit detection & authentication. 

The vision of GS1 India is to significantly enhance patient safety through the elimination of medication errors, track & trace, product recalls, counterfeit detection & authentication of medicines & medical devices.

Ravi Mathur is the CEO of GS1 India

Comments (+)